Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Arbor Dykema
An Adapted Anti-Ctla4 Therapeutic Aimed at Mitigating the Toxicities of Checkpoint Inhibition
Journal of Clinical Investigation
Medicine
Related publications
Immune Checkpoint Inhibition by Anti-Pdcd1 (Anti-Pd1) Monoclonal Antibody Has Significant Therapeutic Activity Against Central Nervous System Lymphoma in an Immunocompetent Preclinical Model
British Journal of Haematology
Hematology
1210 Enhancing the Therapeutic Efficacy of Immune Checkpoint Inhibition and Targeted Therapy Using Anti-Tumor Antibodies in Mouse Melanoma
Journal of Investigative Dermatology
Biochemistry
Dermatology
Cell Biology
Molecular Biology
Combining Anti-Ctla4 With RG7787, an Immunotoxin Targeting Mesothelin, Promotes Tumor Eradication
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Immune Checkpoint Inhibitors: Navigating a New Paradigm of Treatment Toxicities
Asia-Pacific Journal of Clinical Oncology
Medicine
Oncology
Preparative Immunotherapy With Anti-Ox40 and Anti-Ctla4 Improves the Response to Chemotherapy
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Toxicities of Immune Checkpoint Inhibitors: Itis-Ending Adverse Reactions and More
Cureus
Inhibition of the Spindle Assembly Checkpoint Kinase MPS-1 as a Novel Therapeutic Strategy in Malignant Mesothelioma
Oncogene
Cancer Research
Genetics
Molecular Biology
Checkpoint Inhibition May Trigger the Rare Variant of Anti-Lad-1 IgG-Positive, Anti-Bp180 NC16A IgG-Negative Bullous Pemphigoid
Frontiers in Immunology
Allergy
Immunology
Checkpoint Inhibition Before Haploidentical Transplantation in Relapsed or Refractory Hodgkin Lymphoma Patients Is Associated With Higher PFS Without Increased Toxicities
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
